Teva Pharmaceutical announced that the Food and Drug Administration approved QNasl (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis in children ages 4 years to 11 years.
Shara Rudner, director, clinical trials group for Restore Health, was part of a research collaboration that developed a new delivery system that could help millions of people who suffer from seasonal allergies.
The allergy remedy business is growing, and not just because of new entries to the market like Chattem’s Nasacort 24HR, which to date has brought in more than $50 million to the category. Allergy seasons are lasting longer, and there are more people suffering from allergies.
The National Advertising Division on Wednesday determined that Chattem can support certain advertising claims for “Nasacort Allergy 24HR,” an over-the-counter allergy relief medication. The claims were challenged by Merck Consumer Care.
The U.S. Global Research Program in May issued an 800-page National Climate Assessment report that does not bode well for the more than 50 million Americans with allergies and asthma — their already terrible symptoms are about to get worse.
With the ragweed season getting longer and longer, according to government reports, allergy has become a significant driver behind trips to the eye care aisle, and represents a much broader potential patient base. In response to rising temperatures, ragweed pollen season length increased between 1995 and 2011 by as much as 11 days (to 27 days) in parts of the United States and Canada.
The need state for allergy remedies is significant, according to documents filed by Merck recently in support of its application to switch Singulair. Allergies represent the fifth most-common chronic disease in the United States, impacting 1-in-5 Americans. As many as 90% of allergy sufferers self-treat their condition, and 58% only use an OTC or herbal remedy to relieve their allergy symptoms.
Allergy season is at full strength, and it already seems to be one for the record books. Many patients are turning to their pharmacist to ask about the symptoms they are experiencing and why they feel so much worse than in years past. The answer — simple to some and hard to believe for others — is climate change.
In time for spring allergy season, Procter & Gamble has introduced Febreze Fabric Refresher Allergen Reducer, a product that eliminates odors and reduces up to 95% of inanimate allergens from pollen, pet dander and dust mite matter that can become airborne from fabrics after making their way into the home.
Teva Pharmaeceuticals on Tuesday announced that the Food and Drug Administration accepted the company's supplemental new drug application for a lower dose QNASL (beclomethasone dipropionate) nasal aerosol, which is used for the treatment of seasonal and perennial allergic rhinitis in children ages 4 years to 11 years.
The Obama Administration on Tuesday unveiled the Third U.S. National Climate Assessment, a scientific report about climate changes that are happening now in the United States and how they are impacting the nation's health, with longer allergy seasons, for example.
Greer Labs announced the launch and commmercial availability of Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablets.